美股详情

本页面由Tiger Trade Technology Pte. Ltd.提供服务

Frazier Life Sciences Acquisition II (Stock-Only)

10.30

+0.03000.29%

成交量：2.00万

成交额：20.59万

市值：9,965.25万

市盈率：- -

高：10.32

开：10.30

低：10.27

收：10.27

52周最高：10.63

52周最低：10.18

股本：967.50万

流通股本：700.00万

量比：0.30

换手率：0.29%

股息：- -

股息率：- -

净资产收益率：--

总资产收益率：--

市净率：--

市盈率(LYR):- -

数据加载中...

总览公司新闻资讯公告

公司资料

公司名字：

Frazier Life Sciences Acquisition II (Stock-Only)

交易所：

NASDAQ

成立时间：

2026

员工人数：

- -

公司地址：

1001 Page Mill Road,Building 4, Suite 200B,Palo Alto,California,United States

官网：

- -

邮编：

94304

电话：

传真：

- -

简介：

Frazier Life Sciences Acquisition Corp. II是一家新组建的空白支票公司，于2026年8月7日注册成立，为开曼群岛豁免有限责任公司，目的是与一个或多个企业或实体进行合并、兼并、股份交换、资产收购、股份购买、重组或类似业务合并。

董事

名称

职位

Albert Cha

Chief Executive Officer and Director

Benjamin L. Palleiko

Chairman of the Board and Director

R. Scott Struthers

Director

William C. Fairey, Jr.

Director

股东

名称

职位

Albert Cha

Chief Executive Officer and Director

Fran Adams

Chief Financial Officer

Ali Jackson

General Counsel

Kevin Li

Chief Business Officer

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/hans/stock/FLSC/company"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"FLSC","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"FLSC\",,,,,undefined,":{"symbol":"FLSC","market":"US","secType":"STK","nameCN":"Frazier Life Sciences Acquisition II (Stock-Only)","latestPrice":10.3,"timestamp":1792785600000,"preClose":10.27,"halted":0,"volume":20001,"delay":0,"changeRate":0.0029211295034080953,"floatShares":7000000,"shares":9675000,"eps":0,"marketStatus":"盘后交易","change":0.03,"latestTime":"10-23 18:36:00 EDT","open":10.3,"high":10.32,"low":10.265,"amount":205935,"amplitude":0.005355,"askPrice":11.24,"askSize":100,"bidPrice":9.31,"bidSize":100,"shortable":3,"etf":0,"ttmEps":0,"tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1792800000000},"marketStatusCode":4,"adr":0,"listingDate":1791950400000,"exchange":"NASDAQ","adjPreClose":10.27,"volumeRatio":0.295027},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"FLSC\",,,,,undefined,":{"symbol":"FLSC","floatShares":7000000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.295027,"shares":9675000,"dividePrice":0,"high":10.32,"amplitude":0.005355,"preClose":10.27,"low":10.265,"week52Low":10.18,"pbRate":"--","week52High":10.625,"institutionHeld":0,"latestPrice":10.3,"eps":0,"divideRate":0,"volume":20001,"delay":0,"ttmEps":0,"open":10.3,"prevYearClose":10.18,"prevWeekClose":10.35,"prevMonthClose":10.18,"prevQuarterClose":10.18,"fiveDayClose":10.35},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/FLSC\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"FLSC\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"FLSC\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{"companyId":2021015746,"yearFounded":2026,"address":"1001 Page Mill Road,Building 4, Suite 200B,Palo Alto,California,United States","zipCode":"94304","officePhone":"650 325 5156"},"stockCompanyDetail":{"stockEarnings":[{"period":"1week","weight":-0.021},{"period":"1month","weight":0.0088},{"period":"ytd","weight":0.0088}],"compareEarnings":[{"period":"1week","weight":-0.0101},{"period":"1month","weight":-0.0122},{"period":"3month","weight":0.0339},{"period":"6month","weight":0.0701},{"period":"1year","weight":0.144},{"period":"ytd","weight":0.1203}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Frazier Life Sciences Acquisition Corp. II是一家新组建的空白支票公司，于2026年8月7日注册成立，为开曼群岛豁免有限责任公司，目的是与一个或多个企业或实体进行合并、兼并、股份交换、资产收购、股份购买、重组或类似业务合并。","exchange":"NASDAQ","name":"Frazier Life Sciences Acquisition II (Stock-Only)","nameEN":"Frazier Life Sciences Acquisition II (Stock-Only)"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"FLSC\",market:\"US\",,,undefined,":{"directors":[{"name":"Albert Cha","position":"Chief Executive Officer and Director"},{"name":"Benjamin L. Palleiko","position":"Chairman of the Board and Director"},{"name":"R. Scott Struthers","position":"Director"},{"name":"William C. Fairey, Jr.","position":"Director"}],"executives":[{"name":"Albert Cha","position":"Chief Executive Officer and Director"},{"name":"Fran Adams","position":"Chief Financial Officer"},{"name":"Ali Jackson","position":"General Counsel"},{"name":"Kevin Li","position":"Chief Business Officer"}]}}}